A carregar...
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection
SARS-CoV-2 poses a public health threat for which therapeutic agents are urgently needed. Herein, we report that high-throughput microfluidic screening of antigen-specific B-cells led to the identification of LY-CoV555, a potent anti-spike neutralizing antibody from a convalescent COVID-19 patient....
Na minha lista:
| Publicado no: | bioRxiv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cold Spring Harbor Laboratory
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7536866/ https://ncbi.nlm.nih.gov/pubmed/33024963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.09.30.318972 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|